Impact of low- and high-molecular-mass components of human serum on NAMI-A binding to transferrin

作者: K. Śpiewak , M. Brindell

DOI: 10.1007/S00775-015-1255-5

关键词:

摘要: Imidazolium trans-tetrachloridodimethylsulfoxideimidazolruthenate(III), NAMI-A, a novel antimetastatic ruthenium complex was investigated towards affinity to transferrin (Tf), whether Tf-Ru adducts might be formed after its intravenous injection. Studies were focused on the holotransferrin due preferential binding receptor. Here, we showed that is able bind NAMI-A as readily apotransferrin. The simulation of biological conditions human serum performed by application simplified models allowed analyse distribution between and albumin. presence physiological concentration albumin (ca. 18-fold excess over Tf) resulted in twofold decrease Tf. Interestingly, introducing low-molecular-mass components dramatically increased ruthenation Intermolecular competition studies both proteins bound similar amount species. Investigation Tf this protein not major partner for Ru complex. However, spite many competing still observed. lack free species (protein unbounded) incubation with make an assumption high proteins.

参考文章(46)
A. Bergamo, L. Messori, F. Piccioli, M. Cocchietto, G. Sava, Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrin Investigational New Drugs. ,vol. 21, pp. 401- 411 ,(2003) , 10.1023/A:1026243000320
J Williams, K Moreton, The distribution of iron between the metal-binding sites of transferrin human serum Biochemical Journal. ,vol. 185, pp. 483- 488 ,(1980) , 10.1042/BJ1850483
W. L. Delano, The PyMOL Molecular Graphics System DeLano Scientific. ,(2002)
Luigi Messori, Pierluigi Orioli, Daniela Vullo, Enzo Alessio, Elisabetta Iengo, A spectroscopic study of the reaction of NAMI, a novel ruthenium(III)anti-neoplastic complex, with bovine serum albumin. FEBS Journal. ,vol. 267, pp. 1206- 1213 ,(2000) , 10.1046/J.1432-1327.2000.01121.X
Daniel C. Carter, Joseph X. Ho, Structure of serum albumin. Advances in Protein Chemistry. ,vol. 45, pp. 153- 203 ,(1994) , 10.1016/S0065-3233(08)60640-3
F. Kratz, M. Hartmann, B. Keppler, L. Messori, The binding properties of two antitumor ruthenium(III) complexes to apotransferrin. Journal of Biological Chemistry. ,vol. 269, pp. 2581- 2588 ,(1994) , 10.1016/S0021-9258(17)41984-3
W R Harris, Equilibrium Model for Speciation of Aluminum in Serum Clinical Chemistry. ,vol. 38, pp. 1809- 1818 ,(1992) , 10.1093/CLINCHEM/38.9.1809
Aviva Levina, Anannya Mitra, Peter A. Lay, Recent developments in ruthenium anticancer drugs. Metallomics. ,vol. 1, pp. 458- 470 ,(2009) , 10.1039/B904071D
Fadi Bou-Abdallah, Tyson R. Terpstra, The thermodynamic and binding properties of the transferrins as studied by isothermal titration calorimetry. Biochimica et Biophysica Acta. ,vol. 1820, pp. 318- 325 ,(2012) , 10.1016/J.BBAGEN.2011.07.013